These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3434494)
61. [The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]. Isaka S; Fuse H; Akaza H; Moriyama N; Usami M; Kotake T; Matsumura Y; Imai K; Yamanaka H; Matsumoto K Hinyokika Kiyo; 1987 Sep; 33(9):1389-95. PubMed ID: 3434494 [TBL] [Abstract][Full Text] [Related]
62. [Treatment for hormone-refractory or relapsing prostatic cancer]. Hirao Y; Ozono S; Okajima E Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492 [TBL] [Abstract][Full Text] [Related]
63. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
64. Response criteria in research protocols for prostatic cancer. Akaza H Prog Clin Biol Res; 1990; 357():85-95. PubMed ID: 2217483 [TBL] [Abstract][Full Text] [Related]
65. A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma. Eisenberger MA; Bezerdjian L; Kalash S Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063 [TBL] [Abstract][Full Text] [Related]